Clinical trial
A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood
NCT00319215 is registered in ClinicalTrials.gov with Utrecht Institute for Pharmaceutical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood
- Lead sponsor
- Utrecht Institute for Pharmaceutical Sciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- July 31, 2006
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia